P1252: Prevalence, Incidence and Mortality of Pediatric Inflammatory Bowel Disease in CataloniaECCO'25Year: 2025
Authors: Brunet, E.(1)*;Loverdos, I.(2);Vela, E.(3);Comalrena de Sobregrau, C.(4);Garcia-Tirado, D.(4);Melcarne, L.(1);Pontes, C.(3);Llovet, L.P.(1);Garcia-Sague, B.(1);Frisancho, L.E.(1);Lario, S.(1);Puy, A.(1);Ramirez-Lazaro, M.J.(1);Villoria, A.(1);Calvet, X.(1);
(1)Hospital Universitari Parc Tauli, Servei Aparell Digestiu, Sabadell, Spain;(2)Hospital Sant Joan de Deu, Servei de Pediatria, Barcelona, Spain;(3)Servei Catala de la Salut- Generalitat de Catalunya, Unitat d’Informacio i Coneixement., Barcelona, Spain;(4)Hospital Universitari Parc Tauli, Servei de Pediatria. Unitat de Gastroenterologia- Hepatologia i Nutrició Pediàtrica, Sabadell, Spain;
N/A
P1253: Temporal Trend of Opioid Prescriptions Among Adults with Ulcerative Colitis: A Nationwide Cohort Study in Sweden 2008-2021ECCO'25Year: 2025
Authors: Osooli, M.(1)*;Voghera, S.(1);Bruze, G.(1);Nordenvall, C.(2,3);Myrelid, P.(4,5);Everhov, Å.H.(1,6);Ludvigsson, J.F.(7,8);Olén, O.(1,6,9);
(1)Karolinska Institutet, Department of Medicine Solna, Stockholm, Sweden;(2)Karolinska University Hospital-, Department of Molecular Medicine and Surgery, Stockholm, Sweden;(3)Karolinska University Hospital, Department of Pelvic Cancer- Unit of IBD-surgery, Stockholm, Sweden;(4)Linköping University Hospital, Department of Surgery, Linköping, Sweden;(5)Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden;(6)Karolinska Institutet, Department of Clinical Science and Education Södersjukhuset, Stockholm, Sweden;(7)Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden;(8)Örebro University Hospital, Department of Pediatrics, Örebro, Sweden;(9)Stockholm South General Hospital, Sachs’ Children and Youth Hospital, Stockholm, Sweden;
1. Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep, 2018. 67(5152): p. 1419-1427.
2. Opioid Use Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol, 2021. 19(5): p. 895-907 e4.
P1254: The impact of vitamin D supplementation on clinical outcomes in Inflammatory Bowel Disease: a regression discontinuity analysisECCO'25Year: 2025
Authors: Sninsky , J.(1);Sansgiry , S.(2);Taylor , T.(3);Perrin , M.(1);Kanwal , F.(1);Hou , J.(1)*;
(1)Baylor College of Medicine, Department of Medicine, Houston, United States;(2)Baylor College of Medicine, Center for Innovations in Quality- Effectiveness- and Safety IQuESt, Houston, United States;(3)Baylor College of Medicine, Institute for Clinical and Translational Research, Houston, United States;
P1255: Impact of depression on health related quality of life in Ulcerative Colitis patients-are we doing enough? A single tertiary center experienceECCO'25Year: 2025
Authors: Jaksic, D.(1)*;Vuksanovic, S.(2);Toplicanin , A.(2);Spiric--Milovancevic, J.(2);Maric, G.(3);Sokic-Milutinovic, A.(2,4);
(1)Clinical Hospital Center Zemun, Department of Gastroenterology and Hepatology, Belgrade, Serbia;(2)University Clinical Center of Serbia, Clinic for Gastroenterology and Hepatology, Belgrade, Serbia;(3)University of Belgrade, Faculty of Medicine- Institute of Epidemiology, Belgrade, Serbia;(4)University of Belgrade, Faculty of Medicine, Belgrade, Serbia;
P1256: Prevalence and Predictive Factors of Cutaneous Manifestations in IBD Patients: A Cohort StudyECCO'25Year: 2025
Authors: Darkaoui, D.(1)*;Benmoussa, M.(2);Koulali, H.(2);Zazour, A.(2);Elmqaddem, O.(2);Ismaili, Z.(2);Kharrasse, G.(2);
(1)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, CHU mohamed VI Oujda, Oujda, Morocco;(2)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, CHU mohamed VI, Oujda, Morocco;
P1257: Difficult-to-treat Inflammatory Bowel Disease in Latin American countries: prevalence and clinical characteristics.ECCO'25Year: 2025
Authors: Flores, C.(1)*;Yamamoto, J.(2);Fróes, R.(1);Lasa, J.S.(3);Balderramo, D.(4);Martinez, S.B.(5);Baños, F.J.(6);Iade, B.(7);Gomes, T.(8);Parra Holguín, N.N.(2);Andrade Zamora, D.A.(9);Azevedo, F.(10);Saes, J.(11);Yaeza Ferreira, A.(10);Veitia, G.(12);
(1)Brazilian Organization for Crohn’s Disease and Colitis GEDIIB, Brazilian Organization for Crohn’s Disease and Colitis GEDIIB, Sao Paulo, Brazil;(2)Pan American Crohn's and Colitis Organization PANCCO, Pan American Crohn's and Colitis Organization PANCCO, Mexico, Mexico;(3)Centro de Educación Médica e Investigaciones Clínica CEMIC, Centro de Educación Médica e Investigaciones Clínica CEMIC, Buenos Aires, Argentina;(4)Hospital Privado Universitário de Córdoba HPUC, Hospital Privado Universitário de Córdoba HPUC, Cordoba, Argentina;(5)Pan American Crohn's and Colitis Organization PANCCO, Pan American Crohn's and Colitis Organization PANCCO, Santo Domingo, Dominican Republic;(6)Pan American Crohn's and Colitis Organization PANCCO, Pan American Crohn's and Colitis Organization PANCCO, Medellín, Colombia;(7)Pan American Crohn's and Colitis Organization PANCCO, Pan American Crohn's and Colitis Organization PANCCO, Montevideo, Uruguay;(8)Johnson & Johnson Innovative Medicine, Immunology / Gastroenterology LATAM, Sao Paulo, Brazil;(9)Pan American Crohn's and Colitis Organization PANCCO, Pan American Crohn's and Colitis Organization PANCCO, Cuenca, Ecuador;(10)Johnson & Johnson Innovative Medicine, Medical Affairs, Sao Paulo, Brazil;(11)Johnson & Johnson Innovative Medicine, Trial Manager, Sao Paulo, Brazil;(12)Pan American Crohn's and Colitis Organization PANCCO, Pan American Crohn's and Colitis Organization PANCCO, Caracas, Venezuela- Bolivarian Republic;
1. Kotze PG, Underwood FE, Damião AOMC, et al. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review. Clin Gastroenterol Hepatol. 2020;18(2):304-312. doi:10.1016/j.cgh.2019.06.030
2. Queiroz NSF, Martins CA, Quaresma AB, Olivera Sendra PA, Ernest-Suarez K, Kotze PG. IBD barriers across the continents: a continent-specific analysis: Latin America. Therap Adv Gastroenterol. 2023;16:17562848231167953. Published 2023 Apr 25. doi:10.1177/17562848231167953
3. Parigi TL, D'Amico F, Abreu MT, et al. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. Lancet Gastroenterol Hepatol. 2023;8(9):853-859. doi:10.1016/S2468-1253(23)00154-1
P1258: Disease course of inflammatory bowel disease unclassified during the first ten years following diagnosis: A prospective European population-based inception cohort – the Epi-IBD cohortECCO'25Year: 2025
Authors: Wewer, M.D.(1)*;Lophaven, S.(2);Lakatos, P.L.(3,4);Gonczi, L.(3);Salupere, R.(5);Kievit, H.A.L.(6);Nielsen, K.R.(7);Midjord, J.(7);Domislovic, V.(8);Krznarić, Ž.(8);Pedersen, N.(9);Kjeldsen, J.(10);Halfvarson, J.(11);Sebastian, S.(12);Goldis, A.(13);Arebi, N.(14,15);Oksanen, P.(16,17);Neuman, A.(18);Andersen, V.(19,20);Katsanos, K.H.(21);Koukoudis, A.(21);Turcan, S.(22);Ellul, P.(23);Kupcinskas, J.(24);Kiudelis, G.(24);Fumery, M.(25);Kaimakliotis, I.P.(26);D’Inca, R.(27);Lombardini, S.(27);Hernandez, V.(28,29);Fernandez, A.(30);Langholz, E.(31);Munkholm, P.(32);Burisch, J.(1);
(1)Hvidovre University Hospital, Gastro Unit- Medical Division, Hvidovre, Denmark;(2)Omicron ApS, Omicron ApS, Copenhagen, Denmark;(3)Semmelweis University, Department of Medicine and Oncology, Budapest, Hungary;(4)McGill University, Division of Gastroenterology, Montreal, Canada;(5)Tartu University Hospital, Division of Gastroenterology, Tartu, Estonia;(6)Regional Hospital Gødstrup, Department of Medicine, Gødstrup, Denmark;(7)National Hospital of the Faroe Islands, Medical Department, Tórshavn, Faroe Islands;(8)University Hospital Centre Zagreb, Department of Gastroenterology- Hepatology and Nutrition, Zagreb, Croatia;(9)Slagelse Regional Hospital, Gastroenterology Department, Slagelse, Denmark;(10)Odense University Hospital, Department of Medical Gastrointestinal Diseases, Odense, Denmark;(11)Örebro University- Faculty of Medicine and Health, Department of Gastroenterology, Örebro, Sweden;(12)Hull University Teaching Hospitals NHS Trust, IBD Unit, Hull, United Kingdom;(13)University of Medicine ‘Victor Babes’, Clinic of Gastroenterology, Timisoara, Romania;(14)St Mark’s National Bowel Hospital, Department of Inflammatory Bowel Disease, London, United Kingdom;(15)Imperial College London, Department of Metabolism- Digestion and Reproduction, London, United Kingdom;(16)Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland;(17)Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland;(18)Regional Hospital Viborg, Medical Diagnostic Centre, Viborg, Denmark;(19)Institute of Regional Health Research- University Hospital of Southern Denmark, Research Unit of Molecular Diagnostics and Clinical Research, Aabenraa, Denmark;(20)University of Southern Denmark- Odense- Denmark, Institute of Regional Research, Odense, Denmark;(21)University Hospital and University of Ioannina, Division of Gastroenterology, Ioannina, Greece;(22)Nicolae Testemitanu State University of Medicine and Pharmacy of Moldova, Department of Gastroenterology, Chisinau, Moldova- Republic Of;(23)Mater Dei Hospital, Division of Gastroenterology, Misida, Malta;(24)Lithuanian University of Health Sciences, Department of Gastroenterology, Kaunas, Lithuania;(25)Amiens University Hospital, Gastroenterology Unit, Amiens, France;(26)American Gastroenterology Center- Nicosia, American Gastroenterology Center- Nicosia, Nicosia, Cyprus;(27)University of Padua, Department of Surgical- Oncological and Gastroenterological Sciences, Padova, Italy;(28)Xerencia Xestion Integrada de Vigo- SERGAS, Department of Gastroenterology, Vigo, Spain;(29)Galicia Sur Health Research Institute IIS Galicia Sur- SERGAS-UVIGO, Research Group in Digestive Diseases, Vigo, Spain;(30)Ribera-POVISA Hospital, Department of Gastroenterology, Vigo, Spain;(31)University Hospital Copenhagen – Herlev Hospital, Department of Gastroenterology, Herlev, Denmark;(32)University Hospital Copenhagen – North Zealand Hospital, Department of Gastroenterology, Hillerød, Denmark; Epi-IBD group
P1259: A 15-year analysis of Inflammatory Bowel Disease in Africa using Google TrendsECCO'25Year: 2025
Authors: Moran, H.(1)*;Elmahdi, R.(2);Brusco de Freitas , M.(2);Munk, A.K.(3);Jess, T.(2);
(1)PREDICT Center of Excellence at Aalborg University, Medicine, Bellmore- New York, United States;(2)PREDICT Center of Excellence at Aalborg University, Medicine, Copenhagen, Denmark;(3)Technical University of Denmark, Department of Technology- Management and Economics, Lyngby, Denmark;
1. Hodges P, Kelly P. Inflammatory bowel disease in Africa: what is the current state of knowledge?. Int Health. 2020;12(3):222-230. doi:10.1093/inthealth/ihaa005
2. Nuti SV, Wayda B, Ranasinghe I, et al. The use of google trends in health care research: a systematic review. PLoS One. 2014;9(10):e109583. Published 2014 Oct 22. doi:10.1371/journal.pone.0109583
3. Search Engine Market Share Africa | Statcounter Global Stats [Internet]. [cited 2024 Jun 19]. Available from: https://gs.statcounter.com/search-engine-market-share/all/africa/#monthly-200901-202405
AI was not used to assist with writing this abstract.
P1260: Demographics and Clinical Characteristics of Inflammatory Bowel Disease in the Middle East and North Africa : A Multi-Nation Cross-sectional (MIRAGE) StudyECCO'25Year: 2025
Authors: Shehab, M.(1)*;Azzam, N.(2);Al-Bawardy, B.(3);Abid, S.(3);Bashandi , A.(3);AlShihri , R.(3);Mukhtar, M.(4);Saadah , O.(4);Alharbi, O.(2);Al-Darmaki , A.(5);Al Harthi, S.(6);Al-Ejji, K.(7);Ayash, A.(7);Al sahli , A.(8);Khamees, N.(8);Salem , O.E.(9);Mohamed, E.A.(9);Maher, M.(10);Daba, G.(10);Helal , A.(11);Alnassar, M.(11);Alfadhli, A.(1);Mosli, M.(4);
(1)Mubarak Al-kaber University Hospital, Department of Medicine, Jabriyah, Kuwait;(2)King Saud University, Department of Medicine, Riyadh, Saudi Arabia;(3)Alfaisal University, Medicine, Riyadh, Saudi Arabia;(4)King Abdulaziz University Hospital, Department of Medicine, Jeddah, Saudi Arabia;(5)Royal Hospital, Department of Gastroenterology, Muscat, Oman;(6)Khawlah Hospital, Department of Medicine, Muscat, Oman;(7)Hamad Medical Corporation, Department of Medicine, Doha, Qatar;(8)Jordan University Hospital, Department of Gastroenterology, Amman, Jordan;(9)Alexandria University, Department of Medicine, Alexandria, Egypt;(10)Mansoura University, Department of Medicine, Mansoura, Egypt;(11)Sultan Qaboos University Hospital, Department of Medicine, Seeb, Oman;
1. Hammer T, Langholz E. The epidemiology of inflammatory bowel disease: balance between East and West? A narrative review. Digestive Medicine Research. 2020 Dec 30;3.
2. Adam H, Alqassas M, Saadah OI, Mosli M. Extraintestinal manifestations of inflammatory bowel disease in middle eastern patients. Journal of Epidemiology and Global Health. 2020 Dec;10(4):298-303.
P1261: Reproductive Health Outcomes in Colombian Women with Inflammatory Bowel Disease: A Multicenter Cohort Study on Pregnancy, Fertility, and Disease Impact (REINFORCE Study)ECCO'25Year: 2025
Authors: Parra Izquierdo, V.(1,2)*;Osorio-Castrillon, L.(3);Juliao-Baños, F.(3);Frías-Ordoñez, J.(4);
(1)Hospital Internacional de Colombia, Gastroenterology and Rheumatology, Bucaramanga, Colombia;(2)Cellular and Molecular Immunology Group INMUBO- Universidad El Bosque, Immunology, Bogota, Colombia;(3)Hospital Pablo Tobón Uribe, Gastroenterology, Medellin, Colombia;(4)National University of Colombia, Gastroenterology, Bogotá, Colombia;
P1262: Factors associated with bowel urgency in patients with inflammatory bowel disease – interims analysis of the Health Outcome Observatory (H2O) projectECCO'25Year: 2025
Authors: Schreiner, P.O.(1)*;Fierens, L.(2);Ferrante, M.(3);Primas, C.(4);Dabsch, S.(4);Schilling, V.(4);Frick, A.(4);Reinisch, W.(4);Dejaco, C.(5);Schweiger, K.(4);Ritschl, V.(6);Mosor, E.(6);Long, P.(7);Winkler, E.(4);Mooslechner, T.(4);Wisniowski, K.(4);Kazemi-Shirazi, L.(4);Bäuerle, M.(4);Novacek, G.(4);Stamm, T.(6);
(1)Medical Universitiy of Vienna, Department of Internal Medicine III- Gastroenterology & Hepatology, Vienna, Austria;(2)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)Medicine University Hospitals Leuven, Department of Gastroenterology & Hepatology, Leuven, Belgium;(4)Medical University of Vienna, Department of Internal Medicine III- Gastroenterology & Hepatology, Vienna, Austria;(5)Medical university of Vienna, Department of Internal Medicine III- Gastroenterology and Hepatology, Vienna, Austria;(6)Medical University of Vienna, Institute of Outcomes Research- Center for Medical Data Science, Vienna, Austria;(7)Medical University of Vienna, Institute of Outcomes Research- Center for Medical Statistics- Informatics- and Intelligent Systems, Vienna, Austria;
Fierens L, Carney N, Novacek G, van der Woude CJ, Siegmund B, CasellasF, Borruel N, Huberts AS, Sonnenberg E, Gerold N, Primas C, Hedin CRH,Stamm T, Julsgaard M, Fiorino G, Radice S, Zini MLL, Gross E, Sander C,Arijs I, Vakouftsi VR, Koltai T, Health Outcomes Observatory H O PatientAdvisory Board For Inflammatory Bowel Diseases, Health OutcomesObservatory H2O Steering Committee, Charlafti I, Ferrante M. A CoreOutcome Set for Inflammatory Bowel Diseases: Development andRecommendations for Implementation in Clinical Practice Through anInternational Multi-stakeholder Consensus Process. J Crohns Colitis.2024 Oct 15;18(10):1583-1595. doi: 10.1093/ecco-jcc/jjad195. PMID:38019894.
P1263: Real-World Evidence Needs for Treatment Sequence Disease Modelling in Refractory Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Kodjamanova, P.(1);Sanon, M.(2)*;Dimova, M.(3);Wu, E.(2);Atanasov, P.(4);
(1)Amaris Consulting, Real World Evidence, London, United Kingdom;(2)Janssen Global Services, Global Market Access Immunology, Raritan, United States;(3)Janssen Global Services, HTA Modelling, Horsham, United States;(4)Amaris Consulting, Real World Evidence, Barcelona, Spain;
P1264: Metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with Inflammatory Bowel Disease (IBD). A prospective single-center studyECCO'25Year: 2025
Authors: Pastras, P.(1);Papantoniou, K.(1);Tsounis , E.(1);Kanaloupitis, S.(1);Aggeletopoulou , I.(1);Geramoutsos, G.(1);Sotiropoulos, C.(1);Zisimopoulos, K.(1);Thomopoulos, K.(1);Theocharis, G.(1);Triantos, C.(1)*;
(1)University Hospital of Rio Patras, Division of Gastroenterology- Department of Internal Medicine, Patras, Greece;
P1265: The correlation between Helicobacter pylori infection and iron deficiency in adults with inflammatory bowel disease in TaiwanECCO'25Year: 2025
Authors: Wu , Y.H.(1)*;Chou , J.W.(2);Huang , P.J.(3);
(1)China Medical University Hospital, Center for Digestive Medicine- Department of Internal Medicine, Taichung City, Taiwan;(2)China Medical University Hospital, Center for Digestive Medicine- Department of Internal Medicine-, Taichung, Taiwan;(3)China Medical University Hospital, 1. Center for Digestive Medicine- Department of Internal Medicine, Taichung, Taiwan; 3.\tGraduate Institute of Chinese Medicine School of Chinese Medicine College of Chinese Medicine China Medical University Taichung Taiwan
References
1.Roberta Loveikyte, Menno Boer,Catharina N. van der Meulen, et al. Anemia and iron deficiency in outpatients with inflammatory bowel disease: ubiquitous yet suboptimally managed. J Clin Med 2022;11:6843.
2. Menno Boer. J Clin Med. 2022 Nov 19;11(22):6843. 2.Gisbert J.P., Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am. J. Gastroenterol. 2008;103:1299–1307.
3. Madanchi M., Fagagnini S., Fournier N., Biedermann L., Zeitz J., Battegay E., Zimmerli L., Vavricka S.R., Rogler G., Scharl M., et al. The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort. Inflamm. Bowel Dis. 2018;24:1768–1779.
P1266: Gender Influence on Cutaneous Manifestations in IBD: A Focus on Contraceptive UseECCO'25Year: 2025
Authors: Darkaoui, D.(1)*;benmoussa, M.(2);Koulali, H.(2);Zazour, A.(2);Ouiam, E.(2);Ismaili, Z.(2);Kharrasse, G.(2);
(1)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, CHU mohamed VI Oujda, Oujda, Morocco;(2)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, CHU mohamed VI, Oujda, Morocco;
P1267: Risk of hospital-treated infections in patients with cancer and inflammatory bowel diseaseECCO'25Year: 2025
Authors: Dahl, S.A.M.(1)*;Ehrenstein, V.(1);Pedersen, L.(1);Sørensen, H.T.(1);Siegel, C.(2);Erichsen, R.(1);
(1)Aarhus University, Department of Clinical Epidemiology, Aarhus N, Denmark;(2)Dartmouth College, Department of Epidemiology- Geisel School of Medicine, Hanover- NH, United States;
P1268: Sexual health challenges in inflammatory bowel disease: A population-based cross-sectional studyECCO'25Year: 2025
Authors: Larimore, C.F.(1,2);Jacobsen, H.(1,2)*;Larsen, L.(1,2);Graugaard, C.(3);Andersson, M.(4);Frisch, M.(3,4);
(1)Aalborg University, Center for Molecular Prediction of Inflammatory Bowel Disease- PREDICT- Department of Clinical Medicine, Aalborg, Denmark;(2)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;(3)Aalborg University, Center for Sexology Research- Department of Clinical Medicine, Aalborg, Denmark;(4)Statens Serum Institut, Project SEXUS Group- Department of Epidemiology Research, Copenhagen, Denmark;
P1269: Assessing the prevalence and incidence of recorded fatigue codes amongst IBD patients: A nationwide study from the epi-IIRNECCO'25Year: 2025
Authors: Focht, G.(1,2)*;Buchuk, R.(1);Loewenberg Weisband, Y.(3);Ben-Tov, A.(4);Zacay, G.(5,6);Matz, E.(7);Dotan, I.(6,8);Paltiel, O.(9);Turner, D.(1);
(1)Shaare Zedek Medical Center, The Juliet Keiden Institute of Pediatric Gastroenterology and Nutrition, Jerusalem, Israel;(2)Hebrew University of Jerusalem, Braun School of Public Health and Community Medicine- Faculty of Medicine, Jerusalem, Israel;(3)Clalit Research Institute- Tel Aviv- Israel., Clalit Research Institute- Tel Aviv- Israel., Ramat Gan, Israel;(4)Maccabi Health Services and Tel Aviv University, he Sackler Faculty of Medicine, Tel Aviv, Israel;(5)Meuhedet Health Services, Research Institute, Tel Aviv, Israel;(6)Tel Aviv University, Faculty of Medical and Health Sciences, Tel Aviv, Israel;(7)Leumit Health Services, Leumit Health Services, Tel Aviv, Israel;(8)Rabin Medical Center, Department of Gastroenterology, Petah Tikva, Israel;(9)Hadassah Medical Organization- The Hebrew University of Jerusalem, Braun School of Public Health and Community Medicine, Jerusalem, Israel; The epi-IIRN
P1270: Drugs associated with Microscopic Colitis: a comprehensive pharmacovigilance analysisECCO'25Year: 2025
Authors: Cohen, Y.(1,2)*;Ben-Horin, S.(3,4);Goldman, A.(3,4);
(1)Faculty of Medicine- Hebrew University of Jerusalem, Department of Military Medicine, Jerusalem, Israel;(2)Chaim Sheba Medical Center- Tel-Hashomer 5262000, Arrow Program for Medical Research Education, Ramat-Gan, Israel;(3)Faculty of Medicine- Tel-Aviv University, School of Medicine, Tel-Aviv, Israel;(4)Sheba Medical Center, Department of Gastroenterology, Ramat-Gan, Israel;
P1271: The Astur-Frailty-IBD Study: Prevalence and factors associated with Frailty in elderly patients with Inflammatory Bowel Disease.ECCO'25Year: 2025
Authors: Carballo-Folgoso, L.(1)*;Duque Alcorta, J.M.(2);Varela , P.(3);De Francisco García, R.(1,4);Armesto González , E.(2);Mancebo Mata , A.(3);Pérez-Martínez , I.(1,4);Rodríguez López , P.(2);De Jorge Turrión , M.Á.(3);Castaño-García , A.(1);García-Pérez , C.(5);Martínez Martín , G.(5);Fernández-González, E.(1);Chiminazzo, V.(6);Díaz-Simal , A.(1);Suarez, A.(1,4);Riestra, S.(1,4);
(1)Hospital Universitario Central de Asturias, Gastroenterology Department, Oviedo, Spain;(2)Hospital Universitario San Agustín, Gastroenterology Department, Avilés, Spain;(3)Hospital Universitario de Cabueñes, Gastroenterology Department, Gijón, Spain;(4)Instituto de Investigación Sanitaria del Principado de Asturias DIMISA-ISPA, Diet- Microbiota and Health Group, Oviedo, Spain;(5)Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias FINBA, Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Oviedo, Spain;(6)Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Statistics Unit, Oviedo, Spain;